This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Wistar Institute, University of Pennsylvania. Active years: 2013-2023.
Company Filing History:
2 out of 246 
1 out of 2,645 
Years Active: 2013-2023
Title: Innovations in Lung Cancer Diagnosis by Andrei V Kossenkov
Introduction
Andrei V Kossenkov is a notable inventor based in Huntingdon Valley, Pennsylvania. He has made significant contributions to the field of cancer diagnostics, particularly in lung cancer. With a total of two patents to his name, Kossenkov's work focuses on utilizing gene expression profiles for the diagnosis of lung cancers.
Latest Patents
Kossenkov's latest patents include innovative methods and compositions for diagnosing lung cancer. One patent describes compositions and methods for diagnosing lung cancers using gene expression profiles derived from the blood of a mammalian subject. This method utilizes ten or more selected genes that are characteristic of the disease. Another patent outlines a method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells. This method employs three or more selected genes to provide insights into the disease's presence, stage, or prognosis of recurrence. These patents highlight the importance of gene expression profiles in the early detection and management of non-small cell lung cancer (NSCLC).
Career Highlights
Throughout his career, Kossenkov has worked with esteemed institutions such as The Wistar Institute of Anatomy & Biology and the University of Pennsylvania. His research has contributed to advancements in cancer diagnostics, showcasing his commitment to improving patient outcomes through innovative technologies.
Collaborations
Kossenkov has collaborated with notable colleagues, including Michael Showe and Louise C Showe. These partnerships have further enriched his research and development efforts in the field of cancer diagnostics.
Conclusion
Andrei V Kossenkov's contributions to lung cancer diagnosis through innovative gene expression profiling methods underscore his role as a significant inventor in the medical field. His work continues to pave the way for advancements in cancer detection and treatment.